MedTrace Logo

D-chiro-inositol and AUB

NCT06398145 · Status: NOT_YET_RECRUITING · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2024-05-03

No results posted yet for this study

Summary

Patients with AUB will undergo 6-month treatment with D-chiro-inositol and will fill in questionnaires on AUB, with the evaluation of hormonal serum levels.

Conditions

  • Abnormal Uterine Bleeding

Interventions

DIETARY_SUPPLEMENT

D-chiro-inositol and lactalbumin (high dose)

From 0 to 3 months: 1200mg D-chiro-inositol and 120mg lactalbumin per day

DIETARY_SUPPLEMENT

D-chiro-inositol and lactalbumin (low dose)

From 3 to 6 months: 600mg D-chiro-inositol and 60mg lactalbumin per day

Sponsors & Collaborators

  • University Of Perugia

    lead OTHER

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-06-01
Primary Completion
2025-06-01
Completion
2025-07-01

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06398145 on ClinicalTrials.gov